A detailed history of Fiduciary Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Group LLC holds 24,187 shares of ABBV stock, worth $4.12 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
24,187
Previous 24,168 0.08%
Holding current value
$4.12 Million
Previous $4.15 Million 15.22%
% of portfolio
0.49%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $3,112 - $3,787
19 Added 0.08%
24,187 $4.78 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $44,269 - $51,697
-286 Reduced 1.17%
24,168 $4.15 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $38,516 - $43,886
-241 Reduced 0.98%
24,454 $4.45 Million
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $16,512 - $18,596
-120 Reduced 0.48%
24,695 $3.83 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $2,538 - $2,938
-19 Reduced 0.08%
24,815 $3.7 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $31,139 - $38,751
-235 Reduced 0.94%
24,834 $3.35 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $96,454 - $111,082
667 Added 2.73%
25,069 $4 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $30,368 - $34,973
-210 Reduced 0.84%
24,859 $3.96 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $12,171 - $14,596
-88 Reduced 0.36%
24,402 $3.95 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $49,523 - $56,800
369 Added 1.53%
24,490 $3.67 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $52,570 - $66,834
382 Added 1.61%
24,121 $3.69 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $923 - $1,146
-7 Reduced 0.03%
23,739 $3.61 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $13,106 - $16,583
-122 Reduced 0.51%
23,746 $3.22 Million
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $113,103 - $128,389
-1,063 Reduced 4.26%
23,868 $2.61 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $23,251 - $25,903
221 Added 0.89%
24,931 $2.87 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $20,460 - $22,524
200 Added 0.82%
24,710 $2.76 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $68,416 - $92,369
-850 Reduced 3.35%
24,510 $2.54 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $4,295 - $5,041
50 Added 0.2%
25,360 $2.22 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $14,674 - $19,636
-200 Reduced 0.78%
25,310 $2.49 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $27,541 - $41,756
-427 Reduced 1.65%
25,510 $1.94 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $83,526 - $104,509
-1,158 Reduced 4.27%
25,937 $2.3 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $678,483 - $815,731
-10,773 Reduced 28.45%
27,095 $2.05 Million
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $537,360 - $686,872
-8,179 Reduced 17.76%
37,868 $2.75 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $74,980 - $88,247
-972 Reduced 2.07%
46,047 $3.71 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $192,367 - $237,240
-2,471 Reduced 4.99%
47,019 $4.34 Million
Q3 2018

Oct 18, 2018

SELL
$88.91 - $98.84 $519,145 - $577,126
-5,839 Reduced 10.55%
49,490 $4.68 Million
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $184,318 - $218,090
-2,053 Reduced 3.58%
55,329 $5.13 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $129,734 - $173,726
-1,410 Reduced 2.4%
57,382 $5.43 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $243,244 - $266,738
-2,716 Reduced 4.42%
58,792 $5.69 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $4.3 Million - $5.49 Million
61,508
61,508 $5.47 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.